CDXS - Codexis Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 ARRY (-1.53%) WSM (2.49%) WKHS (8.29%) TLRY (1.83%) SSYS (4.96%) SQQQ (-6.58%) SQ (5.44%) SPY (1.54%) PPSI (5.14%) POSH (6.87%) MGNI (1.88%) LTCUSD (%) JUPW (-2.43%) GSAT (7.55%) CURI (8.59%)

CDXS - Codexis

$18.29 0.7[3.98%]

15 mins delayed data

People also watch : BCPC | PFE | RDS.A | MRK

+Watchlist

1 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$17.59	Open	$17.68
Volume	844.5K	Market Cap	1.134B
Yield		Last Dividend

Day

52 Week

TSMC, BYD, Komatsu, Surface Oncology And...	03/23/21
Every night, Cathie Wood???s Ark Investment Management sends out an email listing the stocks that were bought or sold by the firm's ETFs that day. In ...

Global Proteinase K Market Analysis Repo...	03/01/21
DUBLIN--(BUSINESS WIRE)--The "Proteinase K Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area; By Form, By Regions; Segment For...

Phenylketonuria Treatment Market Analysi...	02/26/21
Global Phenylketonuria Treatment Market Analysis to 2027 is a specialized and in-depth study of the pharmaceutical industry with a special focus on th...

Codexis Factors Likely to Have Influence...	02/24/21
Codexis announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by???

Codexis (CDXS) may be moving closer to p...	01/21/21
Biosciences company Codexis, Inc. (NASDAQ: CDXS) has emerged stronger from a rough patch, supported mainly by the resilience of its partners to the vi...

Global Biocatalysis and Biocatalyst Supp...	01/07/21
DUBLIN--(BUSINESS WIRE)--The "Leadership Quadrant of Biocatalysis and Biocatalyst Suppliers - 2021" report has been added to ResearchAndMarkets.com's ...

Why BlackRock Stock Will Continue to Roc...	12/31/20
Organic growth and strong cash inflows should keep the company atop the asset-management pyramid. Also, Wall Street views on Codexis, IMAX, Alibaba, a...

Codexis Announces Pricing of Public Offe...	12/02/20
REDWOOD CITY, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) ??? Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the prici...

Reviewing Codexis (NASDAQ:CDXS) & New Or...	10/24/20
Codexis (NASDAQ:CDXS) and New Oriental Energy & Chemical (OTCMKTS:NOEC) are both medical companies, but which is the better stock? We will compare the...

Codexis, Inc. (NASDAQ:CDXS) Director Ber...	10/24/20
Codexis, Inc. (NASDAQ:CDXS) Director Bernard J. Kelley sold 2,500 shares of the firm???s stock in a transaction on Wednesday, October 21st. The shares...

Insider Selling: Codexis, Inc. (NASDAQ:C...	10/23/20
Codexis, Inc. (NASDAQ:CDXS) Director Bernard J. Kelley sold 2,500 shares of the business???s stock in a transaction on Wednesday, October 21st. The sh...

Codexis, Inc. (NASDAQ:CDXS) Receives Con...	10/23/20
Shares of Codexis, Inc. (NASDAQ:CDXS) have received an average recommendation of ???Buy??? from the seven ratings firms that are presently covering th...

Covid-19 Positive Impact on Specialty En...	10/15/20
The Report scope furnishes with vital statistics about the current Specialty Enzymes Market status and manufacturers. It analyses the in-depth busines...

Codexis and Molecular Assemblies Partner...	06/23/20
Partnership targets accelerating the commercialization of enzymatic DNA synthesis: Codexis invests cash and protein engineering for equity stake in Mo...

Codexis Announces the Election of New Di...	06/16/20
REDWOOD CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of???

ANALYST RATINGS

3 analyst ratings (Last 3 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

Strong Buy rating	04/12/21
Piper Sandler initiates coverage with Overweight rating and announces Price Target of $32.00

Buy rating	03/01/21
Stifel initiates coverage with Buy rating and announces Price Target of $30.00

Buy rating	02/26/21
HC Wainwright & Co. maintains Buy rating and raises Price Target from $21.00 to $26.00

EARNINGS

Date	2021-02-25 (AMC)	Est. (EPS/Rev.)	($0.12)/ 20.88M
Actual (EPS/Rev.)	$-0.06/ $21.03 M	EPS (TTM)	0

TRADERS TRACKING $CDXS

No traders tracking are currently recommending this stock

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.